JPM vs SEIC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
SEIC presents a contradictory profile characterized by a weak Piotroski F-Score of 3/9, indicating deteriorating financial trends despite exceptionally strong absolute solvency (Debt/Equity 0.01). While the stock trades at a significant discount to its growth-based intrinsic value ($166.09) and analyst targets ($97.43), it sits above its defensive Graham Number ($50.37). Strong profitability metrics, including an ROE of 28.96% and consistent earnings beats, are currently offset by bearish insider selling and a completely bearish technical trend.
Compare Another Pair
Related Comparisons
JPM vs SEIC: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and SEI Investments Company (SEIC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.